How to buy IDEXX Laboratories shares

Own IDEXX Laboratories shares in just a few minutes.

Fact checked

IDEXX Laboratories, Inc (IDXX) is a leading diagnostics & research business based in the US. IDEXX Laboratories is listed on the NASDAQ and employs 9,000 staff. All prices are listed in US Dollars.

How to buy shares in IDEXX Laboratories

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: IDXX in this case.
  5. Research IDEXX Laboratories shares. The platform should provide the latest information available.
  6. Buy your IDEXX Laboratories shares. It's that simple.

How has Coronavirus impacted IDEXX Laboratories's share price?

Since the stock market crash in March caused by coronavirus, IDEXX Laboratories's share price has had significant positive movement.

Its last market close was $363.87, which is 23.57% up on its pre-crash value of $278.11 and 115.75% up on the lowest point reached during the March crash when the shares fell as low as $168.65.

If you had bought $1,000 worth of IDEXX Laboratories shares at the start of February 2020, those shares would have been worth $664.07 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,320.85.

IDEXX Laboratories share price

Use our graph to track the performance of IDXX stocks over time.

IDEXX Laboratories shares at a glance

Information last updated 2020-09-21.
52-week range$168.65 - $407.86
50-day moving average $379.8588
200-day moving average $313.1212
Wall St. target price$427.4
PE ratio 66.9565
Dividend yield N/A (0%)
Earnings per share (TTM) $5.286
Promoted
eToro Free Stocks

Invest in IDEXX Laboratories shares with 0% commission

Other fees may apply. Your capital is at risk.

  • Unlimited trades, with no dealing charges or management fees
  • If your trades get copied you can earn extra money
  • Create an account today in a few minutes

Share dealing platform comparison

Table: sorted by promoted deals first
Data indicated here is updated regularly
Name Product Price per trade Frequent trader rate Platform fees Brand description
Fineco
£2.95
£2.95
Zero platform fee
Fineco Bank is good for share traders and investors looking for a complete platform and wide offer. Your first 50 trades are free with Fineco, until 30/09/2020. T&Cs apply. Capital at risk.
IG
0% commission on US shares, and £3 on UK shares
From £5
£0 - £24 per quarter
IG is good for experienced traders, and offers learning resources for beginners, all with wide access to shares, ETFs and funds. Capital at risk.
Hargreaves Lansdown Fund and Share Account
£11.95
£5.95
No fees
Hargreaves Lansdown is the UK's number one platform for private investors, with the depth of features you'd expect from an established platform. Capital at risk.
eToro Free Stocks
0% commission, no markup, no ticket fee, no management fee
N/A
Withdrawal fee & GDP to USD deposit conversion
Capital at risk. 0% commission but other fees may apply.
Interactive Investor
From £7.99 on the Investor Service Plan
From £7.99 on the Investor Service Plan
No transfer fees or exit fees. £9.99 a month on the Investor Service Plan
Interactive Investor offers everything most investors need. Its flat fees makes it pricey for small portfolios, but cheap for big ones. Capital at risk.
loading

Compare up to 4 providers

Data indicated here is updated regularly
Name Product Minimum deposit Maximum annual fee Price per trade Brand description
Moneyfarm stocks and shares ISA
£1500
0.75%
£0
Hargreaves Lansdown stocks and shares ISA
£100
0.45%
£11.95
Hargreaves Lansdown is the UK's biggest wealth manager. It's got everything you'll need, from beginners to experienced investors. Capital at risk.
Interactive Investor stocks and shares ISA
Any lump sum or £25 a month
£119.88
£7.99
Interactive Investor offers everything most investors need. Its flat fees makes it pricey for small portfolios, but cheap for big ones. Capital at risk.
Saxo Markets stocks and shares ISA
No minimum deposit requirement
0.12%
£8.00
Saxo Markets offers a wide access to a range of stocks, ETFs and funds. Capital at risk.
AJ Bell stocks and shares ISA
£500
0.25%
£9.95
AJ Bell is a good all-rounder for people who to choose between shares, funds, ISAs and pensions. Capital at risk.
Fidelity stocks and shares ISA
£1000 or a regular savings plan from £50
0.35%
£10.00
Fidelity is another good all-rounder, offering a good package at a decent price. Not suited for trading shares. Capital at risk.
Nutmeg stocks and shares ISA
£100
0.75%
£0
Nutmeg offers three types of portfolios. Choose the one that goes with your investment style. Capital at risk.
loading

Compare up to 4 providers

Data indicated here is updated regularly
Name Product Minimum investment Choose from Annual fee Brand description
Moneyfarm Pension
£1,500 (initial investment)
7 funds
0.35%-0.75%
Moneyfarm has pensions that are matched against your risk appetite, goals and planned retirement date. Capital at risk.
PensionBee Pension
No minimum
7 funds
0.5% - 0.95%
Pension Bee is a newbie in the pension market. It helps consolidate your pension plans into one place. Capital at risk.
Hargreaves Lansdown Pension
£100 or £25 a month
2,500 funds
0-0.45%
Hargreaves Lansdown is the UK's biggest wealth manager. It's got three different retirement options. Capital at risk.
Interactive Investor Pension
Any lump sum or £25 a month
Over 3,000 funds
£10/month
interactive investor is a flat-fee platform, which makes it cost effective for larger portfolios. Capital at risk.
Saxo Markets Pension
Saxo Markets Pension
£10
Over 11,000 funds
No annual fee
Saxo Markets gives flexibility and control over your investment strategy. Capital at risk.
AJ Bell Pension
£1,000
Over 2,000 funds
0.05-0.25%
AJ Bell has two different pension options, a self managed pension and one that is managed for you. Capital at risk.
Moneybox Pension
£1
3 funds
0.15% - 0.45% charged monthly
Manage your money with an easy-to-use Moneybox app. Capital at risk.
loading

Compare up to 4 providers

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Capital is at risk.

Is it a good time to buy IDEXX Laboratories stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Is IDEXX Laboratories under- or over-valued?

Valuing IDEXX Laboratories stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of IDEXX Laboratories's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

IDEXX Laboratories's P/E ratio

IDEXX Laboratories's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 67x. In other words, IDEXX Laboratories shares trade at around 67x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

However, IDEXX Laboratories's P/E ratio is best considered in relation to those of others within the diagnostics & research industry or those of similar companies.

IDEXX Laboratories's PEG ratio

IDEXX Laboratories's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 5.2. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into IDEXX Laboratories's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

However, it's sensible to consider IDEXX Laboratories's PEG ratio in relation to those of similar companies.

IDEXX Laboratories's EBITDA

IDEXX Laboratories's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $698.2 million (£0.0 million).

The EBITDA is a measure of a IDEXX Laboratories's overall financial performance and is widely used to measure a its profitability.

To put IDEXX Laboratories's EBITDA into context you can compare it against that of similar companies.

IDEXX Laboratories financials

Revenue TTM $2.5 billion
Operating margin TTM 24.5%
Gross profit TTM $1.4 billion
Return on assets TTM 20.57%
Return on equity TTM 206.87%
Profit margin 18.59%
Book value $3.209
Market capitalisation $30.7 billion

TTM: trailing 12 months

How to short and sell IDEXX Laboratories shares

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "IDXX.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 1.2 million IDEXX Laboratories shares held short by investors – that's known as IDEXX Laboratories's "short interest". This figure is 1.6% up from 1.2 million last month.

There are a few different ways that this level of interest in shorting IDEXX Laboratories shares can be evaluated.

IDEXX Laboratories's "short interest ratio" (SIR)

IDEXX Laboratories's "short interest ratio" (SIR) is the quantity of IDEXX Laboratories shares currently shorted divided by the average quantity of IDEXX Laboratories shares traded daily (recently around 476295.71984436). IDEXX Laboratories's SIR currently stands at 2.57. In other words for every 100,000 IDEXX Laboratories shares traded daily on the market, roughly 2570 shares are currently held short.

To gain some more context, you can compare IDEXX Laboratories's short interest ratio against those of similar companies.

However IDEXX Laboratories's short interest can also be evaluated against the total number of IDEXX Laboratories shares, or, against the total number of tradable IDEXX Laboratories shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case IDEXX Laboratories's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 IDEXX Laboratories shares in existence, roughly 10 shares are currently held short) or 0.0164% of the tradable shares (for every 100,000 tradable IDEXX Laboratories shares, roughly 16 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against IDEXX Laboratories.

Find out more about how you can short IDEXX Laboratories stock.

IDEXX Laboratories's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like IDEXX Laboratories.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

IDEXX Laboratories's total ESG risk score

Total ESG risk: 30.77

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and IDEXX Laboratories's overall score of 30.77 (as at 08/01/2020) is nothing to write home about – landing it in it in the 54th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like IDEXX Laboratories is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

To gain some more context, you can compare IDEXX Laboratories's total ESG risk score against those of similar companies.

IDEXX Laboratories's environmental score

Environmental score: 9.93/100

IDEXX Laboratories's environmental score of 9.93 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that IDEXX Laboratories is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

IDEXX Laboratories's social score

Social score: 14.44/100

IDEXX Laboratories's social score of 14.44 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that IDEXX Laboratories is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

IDEXX Laboratories's governance score

Governance score: 13.89/100

IDEXX Laboratories's governance score puts it squarely in the 6th percentile of companies rated in the same sector. That could suggest that IDEXX Laboratories is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Environmental, social, and governance (ESG) summary

IDEXX Laboratories, Inc was last rated for ESG on: 2020-08-01.

Total ESG score 30.77
Total ESG percentile 53.74
Environmental score 9.93
Environmental score percentile 6
Social score 14.44
Social score percentile 6
Governance score 13.89
Governance score percentile 6

IDEXX Laboratories share dividends

We're not expecting IDEXX Laboratories to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.

You may also wish to consider:

Have IDEXX Laboratories's shares ever split?

IDEXX Laboratories's shares were split on a 2:1 basis on 16 June 2015. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your IDEXX Laboratories shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for IDEXX Laboratories shares which in turn could have impacted IDEXX Laboratories's share price.

IDEXX Laboratories share price volatility

Over the last 12 months, IDEXX Laboratories's shares have ranged in value from as little as $168.65 up to $407.86. A popular way to gauge a stock's volatility is its "beta".

IDXX.US volatility(beta: 0.8)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while IDEXX Laboratories's is 0.8049. This would suggest that IDEXX Laboratories's shares are less volatile than average (for this exchange).

To put IDEXX Laboratories's beta into context you can compare it against those of similar companies.

IDEXX Laboratories overview

IDEXX Laboratories, Inc., together with its subsidiaries, develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers that are used in the human point-of-care medical diagnostics market. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Frequently asked questions

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site